---
title: "Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 2315... — FDA record D-0077-2023 | Is It on Recall"
description: "Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency."
url: https://isitonrecall.com/recall/fda-drug-d-0077-2023-desmopressin-acetate-tablet-0-2-mg-100-count-box-rx-only-source-ndc-23155-0490-01-mfg-avet-pharmaceu/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc... — FDA record D-0077-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 5, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
- **Reason**: Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
- **Classification**: Class II
- **Recalling firm**: RemedyRepack Inc.
- **Quantity**: 9 boxes
- **Agency-reported status**: Terminated
- **Source record identifier**: D-0077-2023

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0077-2023%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

Product was distributed to two different customers in MI.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Michigan](https://isitonrecall.com/state/michigan/)

## Dates in the source

- **Report date**: Dec 14, 2022
- **Recall initiation date**: Dec 5, 2022
- **Center classification date**: Dec 7, 2022
- **Termination date**: Feb 3, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0077-2023%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [RemedyRepack Inc. records](https://isitonrecall.com/brand/remedyrepack-inc/)